Get Ready for New Options to Treat Seasonal Allergies

You'll see a plethora of new products and Rx-to-OTC switches for seasonal allergies.

Ryaltris (olopatadine/mometasone) will be a new Rx nasal spray.

Lastacaft (alcaftadine) eye drops have now switched from Rx to OTC. Nasonex (mometasone) nasal spray will switch later this year...so will Astepro 0.15% (azelastine), the first nasal antihistamine to go OTC.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote